Home » Newsletters » BioWorld

BioWorld

Jan. 14, 1994

View Archived Issues

APPOINTMENTS AND ADVANCEMENTS

METRA LICENSES OSTEOPOROSIS MARKER TECHNOLOGY

CORRECTION

LTI LICENSES CARRY-OVER PREVENTION TECHNOLOGY

SYNTELLO, NIAID SIGN CRADA FOR CHLAMYDIA VACCINE

ALLIANCE RAISES $16.4M IN PIPE PLACEMENT

FDA APPROVES BIOPOOL TEST KITS

GEN-PROBE'S TB TEST MORE SENSITIVE THAN PCR

MARTEK EXPLORES DHA'S ABILITY TO LOWER CHOLESTEROL

ONCOGENE TO COLLABORATE ON NEW DMD THERAPY

SCICLONE RAISES $46.5M IN PUBLIC OFFERING

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...